MT3 and obesity disorder: Our data revealed that MT3 can suppress 3T3-L1 adipocyte differentiation indirectly by inhibiting the transcriptional activity of PPARγ and by reducing ROS levels in the early stages of adipogenesis, thus providing a potential novel target for the prevention and treatment of obesity.